Oocyte Retrieval

3

Review clinical trials related to Oocyte Retrieval. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Preoperative Indomethacin and Paracetamol for Pain Management During Oocyte Retrieval in IVF Patients

This is a randomized controlled trial evaluating the efficacy of preoperative analgesic medications - Indomethacin (100 mg per rectum) and Paracetamol/Acamol (1,000 mg intravenously) - for pain management during oocyte retrieval in women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Participants needed: 177
Trial details
Phase: Phase 4Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Western Galilee Hospital-NahariyaUpdated: May 4, 2026Locations: 1
Eligibility criteria

Women undergoing oocyte retrieval for IVF or ICSI [+3]

Known allergy or hypersensitivity to Indomethacin, any NSAID, or Paracetamol [+4]

Status: Not yet recruiting

The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization

Ultrasound-guided oocyte retrieval (OR) is a short, but oftentimes painful procedure, during which the follicles are punctured trans-vaginally to obtain oocytes for in vitro fertilization (IVF). Conscious sedation is the most commonly used method of pain relief, yet several studies have shown that more than half of women report moderate to high levels of pain and up to 7% of women report extreme or unacceptable levels of pain during OR. Adjuvant virtual reality (VR) therapy has been explored to reduce psychological stress during dental procedures, burn wound care, colonoscopy, as well as other minor procedures. Hence, the purpose of this study is to evaluate the use of VR technology during IVF treatment, particularly with respect to tolerability, patient satisfaction, and pain reduction during oocyte retrieval.

Participants needed: 50
Trial details
Age: 18-43Biological sex: FemaleType: InterventionalSponsor: Mount Sinai Hospital, CanadaUpdated: Dec 18, 2024
Eligibility criteria

severe visual impairment [+6]

Status: Not yet recruiting

Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.

The PPOS protocol (Progestin-primed Ovarian Stimulation) involves avoiding ovulation during ovarian stimulation with progesterone. It is a reliable and safe protocol that has been widely used in recent years for in vitro fertilization, as it reduces the number of injections needed during controlled ovarian stimulation and is more cost-effective for patients. The aim of this study is to compare two methods of ovarian stimulation for in vitro fertilization: the PPOS protocol (Group A) and the conventional protocol with injected antagonists (Group B). The goal is to determine whether both methods are equally effective in obtaining euploid embryos in the context of double ovarian stimulation.

Participants needed: 144
Trial details
Phase: Phase 4Age: 18-43Biological sex: FemaleType: InterventionalSponsor: GinefivUpdated: Oct 15, 2024
Eligibility criteria

Regular menstrual cycles between 21 and 35 days, inclusive. [+4]

Endometriosis grade III/IV [+1]